The blog written by Ed Silverman on
October 9th, 2012 8:49 am, entitled KV Pharma & Compounding: We Told You So, contains a good summary of the KV v. FDA saga. It also contains some interesting quotes from KV:
“We have not made public the list of compounding pharmacies from whom our
researchers acquired finished product samples. Nor do we know from which
compounding pharmacies FDA acquired samples for its own testing,” he writes us.
“What we do know is that the same facility that produced the compounded drug
formulation which apparently led to the cases of meningitis makes and now is
recalling 17p – a sterile injectable being used in women who are at high risk.”
To read Silverman's entire blog entry, click
here.
No comments:
Post a Comment